RecruitingNot ApplicableNCT06427577

Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites


Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment

40 participants

Start Date

Jun 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

ZhenQi FuZheng granules has been used to improve the immune function of human body, protect the bone marrow and adrenal cortex function and promote the recovery of positive function in traditional Chinese medicine care, especially with the immune imbalance diseases like post-surgery, chemotherapy and rhinitis. This project intends to establish AR(allergic rhinitis)specimen library, cell and animal model experiment, combining clinical cohort research with applied basic research, further assess the therapeutic mechanism of ZhenQiFuZheng granules in AR. We assume that ZhenQi FuZheng granules could cause the metabolic omics changes of nasal inflammatory factors and nasal secretions in AR patients, thus improving the type 2 inflammation level of allergic rhinitis.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria2

  • Adult patients (18-65 years).
  • Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .

Exclusion Criteria2

  • Patients who refused to accept specimen and questionnaire collection.
  • Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGZhenQi FuZheng granules (ShiDaiYangGuang)

1 bag at a time, twice a day. Oral orally for 4 weeks.


Locations(1)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06427577


Related Trials